LCNUK Webinar - TKI Therapy in EGFR Gene Mutation Lung Cancers and Interpreting Clinical Trials

For our second webinar of the year we are joined by Dr Alastair Greystoke, who is an Honorary Medical Oncologist at Newcastle’s Northern Centre for Cancer Care specialising in lung cancer, frailty in cancer, personalised medicine and drug development. He is also a Lecturer in Medical Oncology at Newcastle University.

Learning outcomes for this webinar:

- Present and emerging therapies in metastatic disease
- Roles of Osimertinib in earlier stage disease
- “Should I scan my patient's head”?
- “Should I be doing liquid biopsy? When and how?”

All healthcare professionals are welcome to join this webinar and to participate in the Q&A session that will follow the presentation.

This webinar programme has been instigated by Lung Cancer Nursing UK. Sponsorship has been received by AstraZeneca UK Ltd to support the costs of this webinar series. AstraZeneca has had no input into the development of topics, selection of speakers or the content of the webinars

If you wish to learn more about AstraZeneca’s lung cancer brands please reach out to your local AstraZeneca Oncology Account Manager.